Mode
Text Size
Log in / Sign up

Systematic review and meta-analysis links D-dimer and ultrasound findings to recurrent venous thromboembolism riskDoctors find high D-dimer levels and ultrasound results predict higher risk of blood clot return

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note very low-certainty evidence linking D-dimer or RVT to recurrent VTE risk.

This systematic review and meta-analysis examined 48 articles to assess the relationship between specific imaging and biomarker findings and the recurrence of venous thromboembolism. The scope included recurrent deep venous thrombosis, pulmonary embolism, and venous thromboembolism, though the specific population and setting were not reported in the source data.

The analysis identified two primary outcomes associated with increased risk. Residual vein thrombosis at anticoagulation discontinuation was linked to a two-fold increase in risk of recurrent venous thromboembolism, with an odds ratio of 2.00 and a 95% CI of 1.02 to 3.94. A positive post-treatment D-dimer also showed an elevated risk, with an odds ratio of 2.48 and a 95% CI of 1.85 to 3.33.

The authors note significant limitations including significant heterogeneity, wide prediction intervals, and inconsistent association across the included studies. Causality is not established, and the evidence is rated as very low certainty. Consequently, biomarkers should be interpreted with caution as isolated predictors in clinical practice rather than definitive indicators of recurrence.

A large review looked at forty-eight different studies to understand how to predict blood clot problems coming back. Doctors checked for leftover clots in veins and high levels of a protein called D-dimer after patients stopped taking blood thinners. They found that people with these signs were much more likely to have another clotting event.

Specifically, having a small clot left behind doubled the risk of the main problem returning. This means patients face about twice the chance of needing treatment again compared to those without this sign. The review also found that high D-dimer levels after treatment were a strong warning sign for future issues.

However, the evidence is not very strong because different studies gave different answers. Some results did not match up well, making it hard to be sure about the exact risks. Doctors warn that these tests should not be used alone to make big decisions about patient care.

In short, these markers show a higher risk but do not prove that a new clot will definitely happen. Medical teams must look at all the patient's health information before changing any treatment plans. Using these tests with caution helps keep patients safe without causing unnecessary worry.

What this means for you:
High D-dimer and leftover clots increase recurrence risk, but evidence is weak and tests should not be used alone.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJan 2026
View Original Abstract ↓
Venous thromboembolic disease is a chronic, recurrent condition. The optimal duration of anticoagulation therapy remains uncertain. We aim to evaluate D-dimer and lower limb ultrasonography as prognostic tools for the recurrence of venous thromboembolism. A search was conducted on May 28, 2022, in the Medline, Embase, and Cochrane databases. Inclusion criteria encompassed cohort studies, case-control studies, and clinical trials. Two reviewers independently screened all records and analyzed studies for inclusion/exclusion criteria, as well as risk of bias, using a structured framework (PROSPERO ID: CRD42022341082). The initial search yielded 4652 titles and abstracts. After removing 777 duplicates and reviewing 3875 titles and abstracts, 48 articles providing information on D-dimer and/or lower limb ultrasonography as prognostic factors were finally included. Very low-certainty evidence suggests that both residual vein thrombosis (RVT) at anticoagulation discontinuation and a positive post-treatment D-dimer are significantly associated with an increased risk of recurrent venous thromboembolism (VTE). For RVT, the pooled analysis showed a two-fold increase in risk (OR 2.00, 95% CI 1.02 to 3.94; I² = 85.7) while for positive D-dimer, the risk was similarly elevated (OR, 2.48; 95% CI, 1.85-3.33; I² = 56.0). In conclusion, very low-quality evidence suggests that abnormal D-dimer and RVT are associated with recurrent VTE; however, this association is inconsistent due to significant heterogeneity and wide prediction intervals. These biomarkers should be interpreted with caution as isolated predictors in clinical practice.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.